Do you want to be part of our pioneering journey to change the way we use mathematical modelling to guide drug discovery and development? Are you an experienced scientist with advanced mathematical and statistical modelling skills and a strong understanding of pharmacokinetic and pharmacodynamic (PKPD) principles? Then apply today and join our modelling department in a 2-years position within the Research and Early Development organization at Novo Nordisk!
The position
In this role, you will combine your proficiency in modelling and simulation within pharmacology, which requires efficient collaboration and communication with subject matter experts within drug discovery projects. You will be part of a growing team that collectively drives the implementation of PKPD methods and engage with scientists across the Research & Early Development organization. Furthermore, you will contribute to a variety of projects and therapeutic areas.
Some of your main responsibilities will include:
Qualifications
You hold a Ph.D. in engineering, physics, math, computer science or other disciplines related to quantitative biology or pharmacology and ideally have 2+ years relevant experience (post PhD) in the pharmaceutical or biotech industry in pharmacometrics, mathematical modelling or machine learning. You have an excellent understanding of theory, principles, and statistical aspects of advanced mathematical modelling preferable including machine learning and have ability to translate these tools into actionable insights.
To succeed in the role, you have:
As a person, you are keen to learn new skills and have a large drive and desire to change the way of working by integrating various types of modelling approaches in decision making in drug discovery projects. You have excellent communication and stakeholder management skills and the ability to effectively interact with colleagues with a variety of backgrounds.
About the department
The Discovery PKPD and Quantitative Systems Pharmacology (QSP) department is growing to support a wide range of discovery drug projects within diseases from diabetes and obesity over hemophilia to growth disorders and a range of rare diseases. The models we develop and apply help to support drug discovery, optimize dose & schedule selection and combination therapy and much more. We work in interdisciplinary teams, with a focus to support and integrate in vitro and in vivo pharmacology data into current or new PKPD, predictive machine learning and/or QSP models to describe the dynamic interactions between drug(s) and biological systems. The models inform and support drug discovery, development and regulatory interactions.
The department is anchored within Global Drug Discovery (GDD) in Research & Early Development (R&ED). The area supports the discovery and development portfolio with pharmacokinetic (PK) and pharmacodynamic (PD) evaluations using a variety of modelling and simulation tools, as well as mechanistic modelling (QSP).
You will have highly skilled and dedicated colleagues supporting projects from early discovery, through non-clinical development, as well as early clinical development. In our daily work, we have close collaboration with all parts of the global Discovery and Development organization, research project teams as well as external collaborators.
Husk at skrive i din ansøgning, at du så jobbet hos Ofir